18 July 2025
18 July 2025
As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.
The US CDC advises that adults aged 50 and older should receive two doses of the shingles vaccine.
There has been a rise in deals and investment to grow US manufacturing operations, due to impending tariffs on the sector.
RPDs have been historically overlooked in the sector of drug development.
The initiative has already seen two pharma and biotech companies chosen for collaboration.
The company aims to focus on high-impact programmes to meet its 2027 financial obligations and support long-term viability.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
